Shares

9 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q4 2023

Jan 12, 2024

SELL
$26.13 - $33.94 $18,055 - $23,452
-691 Reduced 7.99%
7,957 $229,000
Q3 2023

Nov 16, 2023

BUY
$32.09 - $37.51 $10,814 - $12,640
337 Added 4.05%
8,648 $286,000
Q2 2023

Aug 02, 2023

BUY
$36.12 - $41.79 $4,117 - $4,764
114 Added 1.39%
8,311 $304,000
Q4 2022

Feb 28, 2023

SELL
$41.75 - $54.5 $17,117 - $22,345
-410 Reduced 4.76%
8,197 $420,000
Q2 2022

Jul 13, 2022

BUY
$46.53 - $55.17 $11,260 - $13,351
242 Added 2.89%
8,607 $451,000
Q4 2021

Jan 31, 2022

BUY
$41.32 - $61.25 $11,982 - $17,762
290 Added 3.59%
8,365 $494,000
Q2 2021

Jul 14, 2021

SELL
$35.91 - $40.68 $35,730 - $40,476
-995 Reduced 10.97%
8,075 $316,000
Q1 2021

Jun 01, 2021

SELL
$33.49 - $37.77 $2,009 - $2,266
-60 Reduced 0.66%
9,070 $329,000
Q4 2020

Jun 01, 2021

BUY
$33.47 - $42.56 $305,581 - $388,572
9,130 New
9,130 $336,000

Others Institutions Holding PFE

About PFIZER INC


  • Ticker PFE
  • Exchange NYSE
  • Sector Healthcare
  • Industry Drug Manufacturers—General
  • Shares Outstandng 5,612,349,952
  • Market Cap $148B
  • Description
  • Pfizer Inc. discovers, develops, manufactures, markets, distributes, and sells biopharmaceutical products worldwide. It offers medicines and vaccines in various therapeutic areas, including cardiovascular metabolic and women's health under the Premarin family and Eliquis brands; biologics, small molecules, immunotherapies, and biosimilars under ...
More about PFE
Track This Portfolio

Track Mezzasalma Advisors, LLC Portfolio

Follow Mezzasalma Advisors, LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Mezzasalma Advisors, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Mezzasalma Advisors, LLC with notifications on news.